Neurizon inks $1.5M loan against R&D Tax Rebate
Neurizon Therapeutics (ASX:NUZ) retreated in intra-day trade on Wednesday after inking a non-dilutive loan agreement for $1.5 million to fund its current and future operations seeking to treat Huntington’s with its flagship drug NUZ-001.The funds in question are secured against it...
Currently unlisted.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
RPT | Ann: mFund - Removal from Settlement Service - RPT02 | 25/01/21 | 0 | 397 | |||
|
|||||||
RPT | Ann: mFund - Monthly Redemption Report - RPT02 | 20/11/20 | 0 | 345 | |||
|
|||||||
RPT | Ann: mFund - Distribution - RPT02 | 12/11/20 | 0 | 378 | |||
|
|||||||
RPT | Ann: mFund - Monthly Redemption Report - RPT02 | 08/10/20 | 0 | 477 | |||
|
|||||||
RPT | Ann: mFund - Monthly Redemption Report - RPT02 | 12/08/20 | 0 | 356 | |||
|
|||||||
RPT | Ann: mFund - Removal from Settlement Service - RPT02 | 16/07/20 | 0 | 338 | |||
|
|||||||
RPT | Ann: mFund - Monthly Redemption Report - RPT02 | 09/07/20 | 0 | 380 | |||
|
|||||||
RPT | Ann: mFund - Distribution - RPT02 | 24/06/20 | 0 | 374 | |||
|
See All Discussions